Protecting Your Interests: Eagle Pharmaceuticals Shareholder Options in the Class Action Lawsuit12/29/2023
If you suffered losses in Eagle Pharmaceuticals stock, contact Eagle Pharmaceuticals stock loss lawyer Timothy L. Miles
introduction to the EAGLE PHARMACEUTICALS CLASS ACTION LAWSUIT Contact an Eagle Pharmaceuticals Stock Loss Lawyer about an Eagle Pharmaceuticals class action lawsuit
The Eagle Pharmaceuticals class action lawsuit seeks to represent purchasers or acquirers of Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) securities between August 8, 2023 and November 28, 2023, inclusive (the “Class Periodâ€). Captioned Miller v. Eagle Pharmaceuticals, Inc., No. 23-cv-23011 (D.N.J.), the Eagle Pharmaceuticals class action lawsuit charges Eagle Pharmaceuticals and certain of its top current and former executive officers with violations of the Securities Exchange Act of 1934.
​​ If you suffered losses in Eagle Pharmaceuticals stock and wish to serve as lead plaintiff in the Eagle Pharmaceuticals class action lawsuit, please contact Eagle Pharmaceuticals Stock Loss Lawyer Timothy L. Miles by calling 855/846-6529 or via e-mail at [email protected] or by submitting a contact form. Lead plaintiff motions for the Eagle Pharmaceuticals class action lawsuit class action lawsuit must be filed with the court no later than February 9, 2024. In this comprehensive guide, we will navigate the complexities and discuss everything an investor needs to know about the lead plaintiff process and all their options at this point in the Eagle Pharmaceuticals class action lawsuit. THE ALLEGATIONS IN THE EAGLE PHARMACEUTICALS CLASS ACTION LAWSUIT Contact us about an Eagle Pharmaceuticals class action lawsuit if you suffered losses in Eagle Pharmaceuticals stock
​Eagle Pharmaceuticals has several commercialized products, including PEMFEXY, which is a metabolic inhibitor used in combination with chemotherapy for the initial treatment of certain genomic tumor aberrations.
The Eagle Pharmaceuticals class action lawsuit alleges that, throughout the Class Period, defendants failed to disclose that: (i) Eagle Pharmaceuticals was experiencing slower than anticipated pull-though from a wholesale customer predominantly due to expiry of inventory; (ii) as a result, Eagle Pharmaceuticals had overstated its revenue; and (iii) Eagle Pharmaceuticals did not have effective internal controls and procedures over financial reporting as to PEMFEXY sales. The Eagle Pharmaceuticals class action lawsuit alleges that on November 9, 2023 Eagle Pharmaceuticals announced that it would not release its third quarter 2023 results that day (as had been expected) because Eagle Pharmaceuticals “requires more time to review potential adjustments relating to the reporting of sales of PEMFEXY® prior to filing its Form 10-Q†and that Eagle Pharmaceuticals “expects to revise its previously disclosed 2023 full year guidance downward.†On this news, Eagle Pharmaceuticals’ stock price more than 30%, according to the complaint. The Eagle Pharmaceuticals class action lawsuit further alleges that later on November 9, 2023 after the market closed, Eagle Pharmaceuticals disclosed that it was reviewing “potential adjustments to reserves for returns and price adjustments of approximately $15.0 million to $20.0 million†related “to returns and a price adjustment for PEMFEXY stemming from slower-than-anticipated pull-through from a wholesale customer predominantly due to expiry of inventory.†On this news, Eagle Pharmaceuticals’ stock price fell nearly 3%, the complaint alleges. Then, on November 29, 2023, the Eagle Pharmaceuticals class action lawsuit also alleges that Eagle Pharmaceuticals disclosed that its President and CEO, defendant Scott Tarriff, resigned and that Eagle Pharmaceuticals’ board of directors accepted the resignation “[a]fter consideration of various alternatives, including termination with or without cause.†On this news, Eagle Pharmaceuticals’ stock price fell an additional 31%, the complaint alleges. WHAT IS THE LEAD PLAINTIFF DEADLINE IN THE EAGLE PHARMACEUTICALS CLASS ACTION LAWSUIT?
​​When a securities class action is filed such as the Eagle Pharmaceuticals class action lawsuit, the person who files the first complaint is required to publish a notice announcing the filing. Anyone who wants to be lead plaintiff on behalf of the class in the Eagle Pharmaceuticals class action lawsuit must thereafter file a motion to be appointed as lead plaintiff(s) no later than 60 days after the notice was published.
WHAT ARE MY CHOICES IF I RECEIVE A NOTICE IN THE EAGLE PHARMACEUTICALS CLASS ACTION LAWSUIT? Contact an Eagle Pharmaceuticals stock loss lawyer about an Eagle Pharmaceuticals class action lawsuit
​​First, read the notice very carefully. You have two choices. First, you can do nothing and remain a member of the class represented by lead counsel. Second, if you believe you have a large enough loss to justify it, you can opt out of the Eagle Pharmaceuticals class action lawsuit and file your own separate lawsuit. Note, that if you opt out, you will not be able to participate in any settlement or recovery obtained in the Eagle Pharmaceuticals class action lawsuit.
WHAT IS THE LEAD PLAINTIFF PROCESS IN THE EAGLE PHARMACEUTICALS CLASS ACTION LAWSUIT?
​The Private Securities Litigation Reform Act of 1995 permits any investor who purchased and suffered losses in Eagle Pharmaceuticals stock to seek appointment as lead plaintiff in the Eagle Pharmaceuticals class action lawsuit. A lead plaintiff is generally the movant with the greatest financial interest in the relief sought by the putative class who is also typical and adequate of the putative class. ​
​A lead plaintiff acts on behalf of all other class members in directing the class action lawsuit. The lead plaintiff can select a law firm of its choice to litigate the securities class action lawsuit. An investor’s ability to share in any potential future recovery of the class action lawsuit is not dependent upon serving as lead plaintiff. If you suffered losses in Eagle Pharmaceuticals stock and have further questions, contact Eagle Pharmaceuticals stock loss Lawyer Timothy L. Miles today who would fight to recover your damages in an Eagle Pharmaceuticals class action lawsuit if you suffered losses in Eagle Pharmaceuticals stock. CAN A NON-U.S. INVESTOR SERVE AS LEAD PLAINTIFF IN THE EAGLE PHARMACEUTICALS CLASS ACTION LAWSUIT?
​Yes, courts in the U.S. have consistently recognized that non-U.S. investors, many of whom have substantial holdings, are adequate lead plaintiffs and have the same right to move for lead plaintiffs as U.S. investors. Thus, if a non-U.S. investor suffered losses in Eagle Pharmaceuticals​ stock, they may move the Court to be appointed lead plaintiff in the Eagle Pharmaceuticals class action lawsuit.
WHAT ARE THE BENEFITS OF SERVING AS LEAD PLAINTIFF IN THE EAGLE PHARMACEUTICALS LAWSUIT?
Serving as a Lead Plaintiff in the Eagle Pharmaceuticals lawsuit has several advantages and important benefits including:
Thus, there are numerous benefits and other advantages to serving as lead plaintiff in a class action against Eagle Pharmaceuticals​​ if you suffered significant losses in Eagle Pharmaceuticals​​ stock. ​ WHAT RESPONSIBILITIES WILL THE LEAD PLAINTIFF HAVE IN THE EAGLE PHARMACEUTICALS CLASS ACTION LAWSUIT?
​​A Lead Plaintiff owes a fiduciary duty to the class, and therefore, must act in the best interest of the class in the Eagle Pharmaceuticals class action lawsuit. Some of the responsibilities of the Lead Plaintiff in the Eagle Pharmaceuticals class action lawsuit include:
WILL THE LEAD PLAINTIFFS GET MORE MONEY THAN CLASS MEMBERS IF THE EAGLE PHARMACEUTICALS CLASS ACTION LAWSUIT SETTLES?
No, but they may be entitled to recover their reasonable expenses incurred with are directly related to representing the class in the Eagle Pharmaceuticals class action lawsuit. Under the Private Securities Litigation Reform Act of 1995, a Lead Plaintiff is only entitled to his or her pro rata share of any recovery and does not receive any additional money for serving as a representative party on behalf of the class. However, a court, in its discretion, may approve an award of “reasonable costs and expenses (including lost wages)†to a Lead Plaintiff that directly relates to the representation of the class in the Eagle Pharmaceuticals class action lawsuit on behalf of investors who suffered losses in Eagle Pharmaceuticals​ stock. ​
HOW WAS THE CLASS PERIOD DETERMINED IN THE EAGLE PHARMACEUTICALS LAWSUIT?
In a securities fraud class action, the class period refers to a period of time in which it is alleged the price of the company’s stock was artificially inflated due to false and misleading statements made by company executives. The class period starts when the company makes an untrue statement of material fact about the company or fails to disclose a material fact necessary to render other statements not misleading. The class period ends when the truth is revealed to the investing public through a corrective disclosure.
To be a part of the class in the Eagle Pharmaceuticals lawsuit, you must have suffered losses in Eagle Pharmaceuticals​ stock by purchasing during the class period when it is alleged the price of the stock was artificially inflated to be included in the class action against Eagle Pharmaceuticals​​​. HOW CAN AN EAGLE PHARMACEUTICALS STOCK LOSS LAWYER HELP ME IF I SUFFERED LOSSES IN EAGLE PHARMACEUTICALS STOCK?
​​​​​An Eagle Pharmaceuticals stock loss Lawyer is well-versed in the complex laws that govern the securities industry and litigation and focuses on representing individual investors or funds who have been the victims of fraud or who have disputes with investment professionals such as the Eagle Pharmaceuticals lawsuit. Ordinary individual investors, including civil servants, teachers, nurses, and retirees, may need a securities lawyer. In most cases, they have lost money due to mistakes, incompetence, or fraud by an investment professional.
While FINRA, the SEC, and state securities regulators serve a vital role in protecting investors, they simply have too many individuals, firms, and market transactions to monitor to discover every act of fraud or negligence. Individual investors should consult with a securities lawyer if they have lost money due to fraud or stockbroker misconduct. Look for a securities lawyer with experience, high ethical standards, verifiable credentials, and a trustworthy reputation among his peers and the judiciary, as well as testimonials from previous clients and awards and recognitions​​. One name that immediately pops up is nationally known and widely respected Nashville lawyer Timothy L. Miles, who has valuable experience and has received numerous awards, mostly due to his high ethical standards, and hard work ethic, including most recently being named a Top 25 Class action lawyer by the National Trial Lawyers Association, and has maintained an AV rating from Martindale-Hubble since 2014, was named a 2023 Top Rated Litigator and 2023 Top Rated Lawyer by Martindale-Hubble and ALM, and was recently named a 2023 Elite Lawyer of the South by Martindale-Hubble for the fifth year in a row, and was a recipient of Avvo Client’s Choice Award in 2021, in 2022 was featured in the Top 100 Lawyers Magazine and received the Lifetime Achievement Award by Premier Lawyers of America (2019–2021). ​This will most likely be the only call you need to make. (855) 846–6529 or [email protected]. ​ HOW DO I KNOW IF I AM A MEMBER OF THE CLASS IN THE EAGLE PHARMACEUTICALS LAWSUIT?
​​If you purchased shares during the class period and suffered losses in Eagle Pharmaceuticals stock, then you are most likely a member of the class in the Eagle Pharmaceuticals lawsuit and may participate in the Eagle Pharmaceuticals lawsuit since you suffered losses in Eagle Pharmaceuticals​​ stock.
IF I SUFFERED LOSSES IN EAGLE PHARMACEUTICALS STOCK, HOW MUCH CAN I GET OUT OF THE EAGLE PHARMACEUTICALS CLASS ACTION LAWSUIT?
​​In a securities fraud class action lawsuit, the plaintiff’s damages are typically calculated as out-of-pocket losses. These losses are expressed as the difference between the price at which the stock was sold and the price at which the stock would have been sold absent any artificial inflation caused by the defendant’s alleged misrepresentations or omissions which is why you suffered losses in Eagle Pharmaceuticals​ stock. Contact an Eagle Pharmaceuticals stock loss lawyer who could explain your losses in greater detail if you suffered losses in Eagle Pharmaceuticals stock.
WHAT IF I MISS THE LEAD PLAINTIFF DEADLINE IN THE EAGLE PHARMACEUTICALS CLASS ACTION LAWSUIT?
​​​If you purchased shares during the class period and suffered losses in suffered losses in Eagle Pharmaceuticals​ stock, then you will automatically be a class member and entitled to share in any potential settlement or recovery. Your ability to be a class member and recover your losses is not dependent on you serving as a lead plaintiff. The sixty-day deadline applies only to those shareholders seeking to be a lead plaintiff in the Eagle Pharmaceuticals class action lawsuit.
IF I SUFFERED LOSSES IN EAGLE PHARMACEUTICALS STOCK, WHEN CAN I EXPECT TO RECEIVE MY PAYMENT IF THE EAGLE PHARMACEUTICALS LAWSUIT SETTLES?
​If there is a settlement in the Eagle Pharmaceuticals ​lawsuit, you should receive a court-ordered Notice through the mail which will provide a date when the court will hold a final hearing to decide if it will approve the settlement. If your address changed, you may also find lawsuits through sites such as Consumer Action and ClassAction.org along with instructions on how to submit a claim. The Notice will instruct you what you need to do to file a claim. In some class action settlements, you are automatically submitted and need to do nothing further. However, in others, you may be required to submit more information to proceed such as documentation proving your purchase, such as a receipt or brokerage slip or other evidence that you bought or sold Eagle Pharmaceuticals stock during the class period and suffered losses in Eagle Pharmaceuticals stock.
The court will hold a final hearing in the Eagle Pharmaceuticals ​lawsuit on a date provided in the Notice to decide whether to finally approve the settlement. If the Court finally approves the settlement, and there are no objections or appeals, settlement payments will be mailed to all Participating Class Members within a few months. However, if there are objections or appeals, resolving them can take a significant amount of time, perhaps more than a year to resolve the Eagle Pharmaceuticals ​lawsuit. WHAT IS THE DIFFERENCE BETWEEN OBJECTING AND EXCLUDING MYSELF IN THE EAGLE PHARMACEUTICALS​​ LAWSUIT?
​​Objecting is telling the Court you do not believe the settlement in the Eagle Pharmaceuticals ​lawsuit, or some part of it, is fair or reasonable. You can file an objection only if you stay in the Class and do not exclude yourself, and you may submit a Claim Form even if you object to the settlement. On the other hand, requesting exclusion is explicitly telling the Court you do not want to be part of the Class or the Settlement in the class action against Eagle Pharmaceuticals. If you exclude yourself, you cannot object to the Settlement because you no longer have standing as you are not a class member anymore. Similarly, you cannot submit a Claim Form. If you stay in the Class and object, but your objection is overruled, you will not be allowed a second opportunity to exclude yourself.
HOW MUCH DOES IT COST TO HIRE AN EAGLE PHARMACEUTICALS STOCK LOSS LAWYER IF I SUFFERED LOSSES IN EAGLE PHARMACEUTICALS​ STOCK?
Nothing. ​If you suffered losses in Eagle Pharmaceuticals and are a member of the class, it does not cost anything to hire an Eagle Pharmaceuticals stock loss lawyer. Our firm litigates securities fraud cases on a contingent fee basis, so plaintiffs and the class do not pay attorneys’ fees or court costs unless there is a recovery, and the attorney fees and costs are awarded by the court as a percentage of the total recovery for the class. So, contact a Eagle Pharmaceuticals stock loss lawyer today if you suffered losses in Eagle Pharmaceuticals​ ​stock about an Eagle Pharmaceuticals ​lawsuit.
CONTACT AN EAGLE PHARMACEUTICALS​ STOCK LOSS LAWYER TODAY IF YOU SUFFERED LOSSES IN EAGLE PHARMACEUTICALS​ STOCK ABOUT A EAGLE PHARMACEUTICALS CLASS ACTION LAWSUIT
​If you suffered losses in Eagle Pharmaceuticals​​ stock, contact Eagle Pharmaceuticals​ stock loss lawyer Timothy L. Miles today for a free case evaluation about an Eagle Pharmaceuticals class action lawsuit. Call today and see what an Eagle Pharmaceuticals stock loss lawyer could do for you if you suffered losses in Eagle Pharmaceuticals​​​ ​stock.
Eagle Pharmaceuticals​ stock loss lawyer Timothy L. MilesNashville attorney Timothy L. Miles is a nationally recognized shareholder rights attorney raised in Nashville, Tennessee. Mr. Miles has dedicated his career to representing shareholders, employees, and consumers in complex class-action litigation. Whether serving as lead, co-lead, or liaison counsel, Mr. Miles has helped recover hundreds of millions of dollars for defrauded investors, shaped precedent-setting decisions, and delivered real corporate governance reforms. Judges and peers have repeatedly recognized Mr. Miles’ relentless advocacy for the underdog, as well as his unbendable ethical standards. Mr. Miles was recently selected by Martindale-Hubbell® and ALM as a 2022 Top Ranked Lawyer, 2022 Top Rated Litigator. and a 2022 Elite Lawyer ofthe South. Mr. Miles also maintains the AV Preeminent Rating by Martindale-Hubbell®, their highest rating for both legal ability and ethics. Mr. Miles is a member of the prestigious Top 100 Civil Plaintiff Trial Lawyers: The National Trial Lawyers Association,​Class Action: Class Action: Top National Trial Lawyers, National Trial Lawyers Association (2023), a superb rated attorney by Avvo, a recipient of the Lifetime Achievement Award by Premier Lawyers of America (2019) and recognized as a Distinguished Lawyer, Recognizing Excellence in Securities Law, by Lawyers of Distinction (2019); a Top Rated Litigator by Martindale-Hubbell® and ALM (2019-2022); America’s Most Honored Lawyers 2020 – Top 1% by America’s Most Honored (2020-2022). Mr. Miles has published over sixty articles on various issues of the law, including class actions, whistleblower cases, products liability, civil procedure, derivative actions, corporate takeover litigation, corporate formation, mass torts, dangerous drugs, and more. Please visit our website or call for free anytime. Comments are closed.
|
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
October 2024
Categories
All
|
|
CONTACT
The Law Offices of Timothy L. Miles Tapestry at Brentwood Town Center 300 Centerview Dr., #247 Brentwood, TN 37027 Phone: (855) 846-6529 Email: [email protected] HOURS OF OPERATION Mon-Fri: 24/7 Sat-Sun: 24/7 |
SECURITIES FRAUD
GitLab, Inc. Acadia Healthcare Sunlight Financial Iris Energy Limited Edwards Lifesciences Elanco Animal Health, Inc. MASS TORTS
Takata Airbag Settlement |
RSS Feed